{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T22:43:45Z","timestamp":1785537825107,"version":"3.56.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,7,30]],"date-time":"2027-07-30T00:00:00Z","timestamp":1816905600000},"content-version":"am","delay-in-days":394,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["LIPUMA13I0"],"award-info":[{"award-number":["LIPUMA13I0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["LIPUMA15P0"],"award-info":[{"award-number":["LIPUMA15P0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL136647"],"award-info":[{"award-number":["R01HL136647"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R56HL126754"],"award-info":[{"award-number":["R56HL126754"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jcf.2026.03.006","type":"journal-article","created":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T04:38:09Z","timestamp":1773463089000},"page":"651-654","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Density fluctuations of Burkholderia and Achromobacter in cystic fibrosis sputum"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4770-0085","authenticated-orcid":false,"given":"Lisa A.","family":"Carmody","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8658-0867","authenticated-orcid":false,"given":"Lindsay J.","family":"Caverly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda M.","family":"Kalikin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6820-6211","authenticated-orcid":false,"given":"Christina S.","family":"Thornton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard H.","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5727-8164","authenticated-orcid":false,"given":"Donald R.","family":"VanDevanter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"LiPuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcf.2026.03.006_bib0001","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJM199901073400104","article-title":"Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic fibrosis inhaled Tobramycin Study group","volume":"340","author":"Ramsey","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcf.2026.03.006_bib0002","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/ppul.20736","article-title":"A phase 2 study of aztreonam lysine for inhalation to treat patients with cystic fibrosis and Pseudomonas aeruginosa infection","volume":"43","author":"Retsch-Bogart","year":"2008","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2026.03.006_bib0003","doi-asserted-by":"crossref","DOI":"10.1172\/JCI167957","article-title":"Pharmacologic improvement of CFTR function rapidly decreases sputum pathogen density, but lung infections generally persist","volume":"133","author":"Nichols","year":"2023","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jcf.2026.03.006_bib0004","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.jcf.2020.12.012","article-title":"The clinical and microbiological utility of inhaled aztreonam lysine for the treatment of acute pulmonary exacerbations of cystic fibrosis: an open-label randomised crossover study (AZTEC-CF)","volume":"20","author":"Frost","year":"2021","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2026.03.006_bib0005","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jcf.2024.11.013","article-title":"Daily variability of Pseudomonas aeruginosa density in cystic fibrosis sputum","volume":"24","author":"Carmody","year":"2025","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2026.03.006_bib0006","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1128\/JCM.02299-15","article-title":"Culture-based and culture-independent bacteriologic analysis of cystic fibrosis respiratory specimens","volume":"54","author":"Mahboubi","year":"2016","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jcf.2026.03.006_bib0007","doi-asserted-by":"crossref","DOI":"10.1111\/tid.14041","article-title":"Phage therapy in a lung transplant recipient with cystic fibrosis infected with multidrug-resistant Burkholderia multivorans","volume":"25","author":"Haidar","year":"2023","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.jcf.2026.03.006_bib0008","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3390\/v13010060","article-title":"A case of phage therapy against pandrug-resistant Achromobacter xylosoxidans in a 12-year-old lung-transplanted cystic fibrosis patient","volume":"13","author":"Lebeaux","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.jcf.2026.03.006_bib0009","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1513\/AnnalsATS.201903-270OC","article-title":"Measures of cystic fibrosis airway microbiota during periods of clinical stability","volume":"16","author":"Caverly","year":"2019","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.jcf.2026.03.006_bib0010","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.1128\/JCM.01189-11","article-title":"Effect of sample storage conditions on culture-independent bacterial community measures in cystic fibrosis sputum specimens","volume":"49","author":"Zhao","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jcf.2026.03.006_bib0011","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1513\/AnnalsATS.201211-107OC","article-title":"Changes in cystic fibrosis airway microbiota at pulmonary exacerbation","volume":"10","author":"Carmody","year":"2013","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.jcf.2026.03.006_bib0012","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nmeth.3869","article-title":"DADA2: high-resolution sample inference from Illumina amplicon data","volume":"13","author":"Callahan","year":"2016","journal-title":"Nat Methods"},{"key":"10.1016\/j.jcf.2026.03.006_bib0013","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nmeth.f.303","article-title":"QIIME allows analysis of high-throughput community sequencing data","volume":"7","author":"Caporaso","year":"2010","journal-title":"Nat Methods"},{"key":"10.1016\/j.jcf.2026.03.006_bib0014","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1099\/00221287-148-1-257","article-title":"Determination of bacterial load by real-time PCR using a broad-range (universal) probe and primers set","volume":"148","author":"Nadkarni","year":"2002","journal-title":"Microbiol"},{"key":"10.1016\/j.jcf.2026.03.006_bib0015","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s10295-020-02287-3","article-title":"A comparison of culture-based, real-time PCR, droplet digital PCR and flow cytometric methods for the detection of Burkholderia cepacia complex in nuclease-free water and antiseptics","volume":"47","author":"Ahn","year":"2020","journal-title":"J Ind Microbiol Biotechnol"},{"key":"10.1016\/j.jcf.2026.03.006_bib0016","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1136\/thoraxjnl-2019-214187","article-title":"Maintenance tobramycin primarily affects untargeted bacteria in the CF sputum microbiome","volume":"75","author":"Nelson","year":"2020","journal-title":"Thorax"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199326000512?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199326000512?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T20:08:44Z","timestamp":1785528524000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199326000512"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1569199326000512"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2026.03.006","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Density fluctuations of Burkholderia and Achromobacter in cystic fibrosis sputum","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2026.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}